# US 5,349,063 A · Pancreatic imaging agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 5,349,063 A
- Document ID: US5349063A
- Status: Granted
- Kind: A
- Application number: 08/000,546
- Filed: 1993-01-04
- Granted: 1994-09-20
- Earliest claimed: 1991-03-21
- Assignees: Alberta Cancer Board
- Inventors: Alummoottil V. Joshua; John R. Scott
- Web page: https://patentgrep.com/patent/US5349063A

## CPC

- C07D 295/13: to an acyclic saturated chain
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

A novel group of radiolabelled diamines are provided, effective for pancreatic imaging and represented by the formula ##STR1## wherein n is 1 to 10; R.sub.1 and R.sub.2 are the same or different and are hydrogen, hydroxyl or lower alkyl having 1 to 6 carbon atoms; R.sub.3 is lower alkyl having 1 to 6 carbon atoms; and N' is a nitrogen atom forming part of a 4- to 8-membered heterocyclic ring containing one or two hetero atoms, one of which is said nitrogen, said heterocyclic ring being unsubstituted or substituted with one or more lower alkyl groups and pharmaceutically acceptable acid addition salts thereof.

## Claims

### Claim 1

A compound effective for pancreatic imaging having the general formula: ##STR5## wherein n is 3 to 10; R.sub.1 and R.sub.2 are the same or different and are hydroxyl or lower alkyl having 1 to 6 carbon atoms; R.sub.3 is lower alkyl having 1 to 6 carbon atoms; and N' is a nitrogen atom forming part of a 4- to 8-membered heterocyclic ring containing one or two hetero atoms, one of which is said nitrogen, said heterocyclic ring being unsubstituted or substituted with one or more lower alkyl groups and pharmaceutically acceptable acid addition salts thereof.

### Claim 2

A compound effective for pancreatic imaging having the general formula: ##STR6## wherein n is 1 to 10; R.sub.1 and R.sub.2 are the same or different and are hydroxyl or lower alkyl having 1 to 6 carbon atoms; R.sub.3 is lower alkyl having 1 to 6 carbon atoms; and N' is a nitrogen atom forming part of a morpholino or pyrrolidino ring which is unsubstituted or substituted with one or more lower alkyl groups and pharmaceutically acceptable acid addition salts thereof.

### Claim 3 (depends on 1, 2)

A compound in accordance with claim 1 or 2 wherein I is a radioactive isotope of iodine selected from the group consisting of I-121, I-123, I-125 and I-131.

### Claim 4 (depends on 1)

A compound in accordance with claim 1 wherein N' is a nitrogen atom forming part of a morpholino, pyrrolidino or piperidino ring which is unsubstituted or substituted with one or more lower alkyl groups and pharmaceutically acceptable addition salts thereof.

### Claim 5 (depends on 4)

A compound in accordance with claim 4 wherein n is 3.

### Claim 6 (depends on 5)

A compound in accordance with claim 5 wherein R.sub.1 is hydroxyl attached at 2 position of benzene ring of said compound; R.sub.2 is lower alkyl having 1 to 6 carbon atoms and attached at 3 position of said benzene ring and I is attached at 5 position of said benzene ring.

### Claim 7 (depends on 5)

A compound in accordance with claim 5 wherein said compound is I -N[3(4-morpholino) propyl]-N-methyl-2-hydroxy-3-methyl-5-iodobenzylamine and I is a radioactive isotope of iodine selected from the group consisting of I-121, I-123, I-125 and I-131.

### Claim 8 (depends on 4)

A compound in accordance with claim 4 wherein said compound is I-123 N[3(4-morpholino)propyl]-N-methyl-2-hydroxy-3-methyl-5-iodobenzylamine.

### Claim 9 (depends on 4)

A compound in accordance with claim 4 wherein said compound is I- N[3(1-pyrrolidino)propyl]-N-methyl-2-hydroxy-3-methyl-5-iodobenzylamine and I is a radioactive isotope of iodine selected from the group consisting of I-121, I-123, I-125 and I-131.

### Claim 10 (depends on 4)

A compound in accordance with claim 4 wherein said compound is I-123 N[3(1-pyrrolidino)propyl]-N-methyl-2-hydroxy-3-methyl-5-iodobenzylamine.

### Claim 11 (depends on 4)

A compound in accordance with claim 4 wherein said compound is I- N[3(1-piperidino)propyl]-N-methyl-2-hydroxy-3-methyl-5-iodobenzylamine and I is a radioactive isotope of iodine selected from the group consisting of I-121, I-123, I-125 and I-131.

### Claim 12 (depends on 4)

A compound in accordance with claim 4 wherein said compound is I-123 N[3(1-piperidino)propyl]-N-methyl-2-hydroxy-3-methyl-5-iodobenzylamine.